Sort
4,870 grants matching “glp 1”
IMPARIED AMINO-ACID SENSING/SIGNALING IN BONE MARROW OSTEOPROGENITOR CELLS
$274,905Carlos Miguel Isales · Augusta University · P01 · FY2011 · AG
IMPARIED AMINO-ACID SENSING/SIGNALING IN BONE MARROW OSTEOPROGENITOR CELLS
$274,800Carlos Miguel Isales · Augusta University · P01 · FY2012 · AG
LIRAGLUTIDE AS ADDITIONAL TREATMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
$274,772Paresh Dandona · State University Of New York At Buffalo · R01 · FY2012 · DK
Rapid Histone Methyltransferase Profiling with Luminescent Reporters
$274,561Reena Zutshi · Luceome Biotechnologies, Llc · R43 · FY2014 · GM
Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)
$274,510Zachary Rome · Timber Pharmaceuticals, Llc · R01 · FY2018 · FD
KYC Reduces Vasculopathy in Sickle Cell Disease
$274,490Stephen Naylor · Reneurogen, Llc · R43 · FY2018 · HL
LIRAGLUTIDE AS ADDITIONAL TREATMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
$274,263Paresh Dandona · State University Of New York At Buffalo · R01 · FY2016 · DK
IMPARIED AMINO-ACID SENSING/SIGNALING IN BONE MARROW OSTEOPROGENITOR CELLS
$273,758Carlos Miguel Isales · Augusta University · P01 · FY2015 · AG
LIRAGLUTIDE AS ADDITIONAL TREATMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
$273,754Paresh Dandona · State University Of New York At Buffalo · R01 · FY2015 · DK
LIRAGLUTIDE AS ADDITIONAL TREATMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
$273,754Paresh Dandona · State University Of New York At Buffalo · R01 · FY2014 · DK
Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions
$273,730Nira Ben-Jonathan · University Of Cincinnati · U01 · FY2013 · ES
Aging And The Pancreas
$273,344Josephine Egan · National Institute On Aging · ZIA · FY2009 · AG
Drug Development of GLP-1 receptor agonists
$273,344Josephine Egan · National Institute On Aging · ZIA · FY2009 · AG
Investigational Safety and Toxicity Studies of Subcutaneous COG1410 for Alzheimer
$273,242Michael Peter Vitek · Cognosci, Inc. · R43 · FY2013 · AG
Pediatric Type 1 diabetes: Intervention Trials With Glucagon Suppressors
$272,765Rubina A Heptulla · Baylor College Of Medicine · R01 · FY2006 · DK
Biochemically counteracting maladaptive functions of G9a/GLP in addiction
$272,395Bassem Al-Sady · University Of California, San Francisco · R21 · FY2025 · DA
Chronic exposure to Biphenol A and uterine cancer risk markers
$272,032Shuk-Mei Ho · University Of Cincinnati · U01 · FY2014 · ES
ROLE OF PRESENILIN IN NOTCH AND APP MATURATION
$272,011Washington University · R01 · FY2001 · AG
Pathology
$271,076Thomas March · Lovelace Biomedical & Environmental Research Institute · U54 · FY2010 · NS
Pediatric Type 1 diabetes: Intervention Trials With Glucagon Suppressors
$270,729Rubina A Heptulla · Baylor College Of Medicine · R01 · FY2007 · DK
BCG overexpressing a small molecule STING agonist as a vaccine for TB
$270,176Todd Wallach · Oncosting Llc · R44 · FY2024 · AI
Phase 2A Study of Exendin for the Treatment of Congenital Hyperinsulinism
$270,107Diva Del Carmen De Leon · Children'S Hosp Of Philadelphia · R01 · FY2014 · FD
CORE--BIOPROCESS AND PURIFICATION
$270,039University Of Virginia Charlottesville · U54 · FY2000 · HD
Molecular Basis of Antidiabetogenic Hormone Action
$269,255George G Holz · Upstate Medical University · R01 · FY2009 · DK
FGF-2 mimetic peptides as pleuripotent mitigators of ARS and DEARE
$267,750Paul Okunieff · University Of Maryland Baltimore · U19 · FY2021 · AI